Mettler-Toledo International, Inc. (NYSE:MTD) Receives $1,435.42 Consensus PT from Analysts

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have received an average rating of “Hold” from the thirteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $1,435.4167.

Several equities research analysts recently commented on MTD shares. Wall Street Zen upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barclays cut their target price on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 target price for the company. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a research note on Monday, December 15th. Finally, Stifel Nicolaus increased their price objective on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, November 10th.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,393.87 on Thursday. The stock’s 50-day simple moving average is $1,413.01 and its 200-day simple moving average is $1,370.61. The firm has a market capitalization of $28.34 billion, a PE ratio of 33.09, a price-to-earnings-growth ratio of 2.89 and a beta of 1.42. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the company posted $12.41 earnings per share. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, sell-side analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the transaction, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,456,714.56. The trade was a 13.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.77% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds and other institutional investors have recently made changes to their positions in MTD. Geneos Wealth Management Inc. grew its stake in shares of Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after purchasing an additional 30 shares during the last quarter. CWM LLC increased its position in Mettler-Toledo International by 32.1% during the 2nd quarter. CWM LLC now owns 868 shares of the medical instruments supplier’s stock worth $1,020,000 after purchasing an additional 211 shares during the period. Allianz Asset Management GmbH raised its stake in shares of Mettler-Toledo International by 86.3% during the 2nd quarter. Allianz Asset Management GmbH now owns 4,193 shares of the medical instruments supplier’s stock worth $4,926,000 after buying an additional 1,942 shares in the last quarter. Ethic Inc. lifted its holdings in shares of Mettler-Toledo International by 4.5% in the 2nd quarter. Ethic Inc. now owns 2,549 shares of the medical instruments supplier’s stock valued at $3,019,000 after buying an additional 109 shares during the period. Finally, Asset Management One Co. Ltd. boosted its stake in shares of Mettler-Toledo International by 7.4% in the second quarter. Asset Management One Co. Ltd. now owns 20,401 shares of the medical instruments supplier’s stock valued at $23,965,000 after buying an additional 1,410 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.